▶ 調査レポート

イグラチモドの世界市場予測 2019年:メーカー別、地域別、種類・用途別(~2024)

• 英文タイトル:Global Iguratimod Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。イグラチモドの世界市場予測 2019年:メーカー別、地域別、種類・用途別(~2024) / Global Iguratimod Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 / B-GIR08C2937資料のイメージです。• レポートコード:B-GIR08C2937
• 出版社/出版日:GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、イグラチモドの世界市場について調べ、まとめました。種類別セグメントは、14個/箱、100個/箱等、用途別セグメントは、抗リウマチ薬、免疫調節薬、その他等に区分しました。イグラチモドの世界市場概観、企業動向、企業別イグラチモドシェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・イグラチモドの市場概観
・イグラチモドの企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・イグラチモドの企業別販売動向、市場シェア、市場集中度、競争動向
・イグラチモドの世界市場規模
・イグラチモドの北米市場分析(アメリカ、カナダ、メキシコ等)
・イグラチモドのアメリカ市場規模推移
・イグラチモドのカナダ市場規模推移
・イグラチモドのメキシコ市場規模推移
・イグラチモドのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・イグラチモドのドイツ市場規模推移
・イグラチモドのイギリス市場規模推移
・イグラチモドのロシア市場規模推移
・イグラチモドのアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・イグラチモドの日本市場規模推移
・イグラチモドの中国市場規模推移
・イグラチモドの韓国市場規模推移
・イグラチモドのインド市場規模推移
・イグラチモドの東南アジア市場規模推移
・イグラチモドの南米市場分析(ブラジル、アルゼンチン等)
・イグラチモドの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・イグラチモドの種類別分析/販売量、売上、市場シェア(14個/箱、100個/箱)
・イグラチモドの用途別分析/市場規模(抗リウマチ薬、免疫調節薬、その他)
・イグラチモドの市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・イグラチモドの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The worldwide market for Iguratimod is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Iguratimod in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Simcere Pharmaceutical
Toyama Chemical
Eisai

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
14 Pcs/Box
100 Pcs/Box

Market Segment by Applications, can be divided into
Antirheumatic
Immunoregulation
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iguratimod product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Iguratimod, with price, sales, revenue and global market share of Iguratimod in 2017 and 2018.
Chapter 3, the Iguratimod competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iguratimod breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Iguratimod market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Iguratimod sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Iguratimod Introduction
1.2 Market Analysis by Type
1.2.1 14 Pcs/Box
1.2.2 100 Pcs/Box
1.3 Market Analysis by Applications
1.3.1 Antirheumatic
1.3.2 Immunoregulation
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Simcere Pharmaceutical
2.1.1 Business Overview
2.1.2 Iguratimod Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Simcere Pharmaceutical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Toyama Chemical
2.2.1 Business Overview
2.2.2 Iguratimod Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Toyama Chemical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eisai
2.3.1 Business Overview
2.3.2 Iguratimod Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eisai Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Iguratimod Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Iguratimod Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Iguratimod Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Iguratimod Manufacturer Market Share in 2018
3.3.2 Top 6 Iguratimod Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Iguratimod Market Analysis by Regions
4.1 Global Iguratimod Sales, Revenue and Market Share by Regions
4.1.1 Global Iguratimod Sales and Market Share by Regions (2014-2019)
4.1.2 Global Iguratimod Revenue and Market Share by Regions (2014-2019)
4.2 North America Iguratimod Sales and Growth Rate (2014-2019)
4.3 Europe Iguratimod Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Iguratimod Sales and Growth Rate (2014-2019)
4.5 South America Iguratimod Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Iguratimod Sales and Growth Rate (2014-2019)
5 North America Iguratimod by Country
5.1 North America Iguratimod Sales, Revenue and Market Share by Country
5.1.1 North America Iguratimod Sales and Market Share by Country (2014-2019)
5.1.2 North America Iguratimod Revenue and Market Share by Country (2014-2019)
5.2 United States Iguratimod Sales and Growth Rate (2014-2019)
5.3 Canada Iguratimod Sales and Growth Rate (2014-2019)
5.4 Mexico Iguratimod Sales and Growth Rate (2014-2019)
6 Europe Iguratimod by Country
6.1 Europe Iguratimod Sales, Revenue and Market Share by Country
6.1.1 Europe Iguratimod Sales and Market Share by Country (2014-2019)
6.1.2 Europe Iguratimod Revenue and Market Share by Country (2014-2019)
6.2 Germany Iguratimod Sales and Growth Rate (2014-2019)
6.3 UK Iguratimod Sales and Growth Rate (2014-2019)
6.4 France Iguratimod Sales and Growth Rate (2014-2019)
6.5 Russia Iguratimod Sales and Growth Rate (2014-2019)
6.6 Italy Iguratimod Sales and Growth Rate (2014-2019)
7 Asia-Pacific Iguratimod by Country
7.1 Asia-Pacific Iguratimod Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Iguratimod Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Iguratimod Revenue and Market Share by Country (2014-2019)
7.2 China Iguratimod Sales and Growth Rate (2014-2019)
7.3 Japan Iguratimod Sales and Growth Rate (2014-2019)
7.4 Korea Iguratimod Sales and Growth Rate (2014-2019)
7.5 India Iguratimod Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Iguratimod Sales and Growth Rate (2014-2019)
8 South America Iguratimod by Country
8.1 South America Iguratimod Sales, Revenue and Market Share by Country
8.1.1 South America Iguratimod Sales and Market Share by Country (2014-2019)
8.1.2 South America Iguratimod Revenue and Market Share by Country (2014-2019)
8.2 Brazil Iguratimod Sales and Growth Rate (2014-2019)
8.3 Argentina Iguratimod Sales and Growth Rate (2014-2019)
8.4 Colombia Iguratimod Sales and Growth Rate (2014-2019)
9 Middle East and Africa Iguratimod by Countries
9.1 Middle East and Africa Iguratimod Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Iguratimod Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Iguratimod Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Iguratimod Sales and Growth Rate (2014-2019)
9.3 Turkey Iguratimod Sales and Growth Rate (2014-2019)
9.4 Egypt Iguratimod Sales and Growth Rate (2014-2019)
9.5 Nigeria Iguratimod Sales and Growth Rate (2014-2019)
9.6 South Africa Iguratimod Sales and Growth Rate (2014-2019)
10 Global Iguratimod Market Segment by Type
10.1 Global Iguratimod Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Iguratimod Sales and Market Share by Type (2014-2019)
10.1.2 Global Iguratimod Revenue and Market Share by Type (2014-2019)
10.2 14 Pcs/Box Sales Growth and Price
10.2.1 Global 14 Pcs/Box Sales Growth (2014-2019)
10.2.2 Global 14 Pcs/Box Price (2014-2019)
10.3 100 Pcs/Box Sales Growth and Price
10.3.1 Global 100 Pcs/Box Sales Growth (2014-2019)
10.3.2 Global 100 Pcs/Box Price (2014-2019)
11 Global Iguratimod Market Segment by Application
11.1 Global Iguratimod Sales Market Share by Application (2014-2019)
11.2 Antirheumatic Sales Growth (2014-2019)
11.3 Immunoregulation Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Iguratimod Market Forecast (2019-2024)
12.1 Global Iguratimod Sales, Revenue and Growth Rate (2019-2024)
12.2 Iguratimod Market Forecast by Regions (2019-2024)
12.2.1 North America Iguratimod Market Forecast (2019-2024)
12.2.2 Europe Iguratimod Market Forecast (2019-2024)
12.2.3 Asia-Pacific Iguratimod Market Forecast (2019-2024)
12.2.4 South America Iguratimod Market Forecast (2019-2024)
12.2.5 Middle East and Africa Iguratimod Market Forecast (2019-2024)
12.3 Iguratimod Market Forecast by Type (2019-2024)
12.3.1 Global Iguratimod Sales Forecast by Type (2019-2024)
12.3.2 Global Iguratimod Market Share Forecast by Type (2019-2024)
12.4 Iguratimod Market Forecast by Application (2019-2024)
12.4.1 Global Iguratimod Sales Forecast by Application (2019-2024)
12.4.2 Global Iguratimod Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Iguratimod Picture
Table Product Specifications of Iguratimod
Figure Global Sales Market Share of Iguratimod by Types in 2018
Table Iguratimod Types for Major Manufacturers
Figure 14 Pcs/Box Picture
Figure 100 Pcs/Box Picture
Figure Iguratimod Sales Market Share by Applications in 2018
Figure Antirheumatic Picture
Figure Immunoregulation Picture
Figure Other Picture
Figure United States Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure France Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure UK Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure China Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure India Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Iguratimod Revenue (Value) and Growth Rate (2014-2024)
Table Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Simcere Pharmaceutical Iguratimod Type and Applications
Table Simcere Pharmaceutical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Toyama Chemical Basic Information, Manufacturing Base and Competitors
Table Toyama Chemical Iguratimod Type and Applications
Table Toyama Chemical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Iguratimod Type and Applications
Table Eisai Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Iguratimod Sales by Manufacturer (2017-2018)
Figure Global Iguratimod Sales Market Share by Manufacturer in 2017
Figure Global Iguratimod Sales Market Share by Manufacturer in 2018
Table Global Iguratimod Revenue by Manufacturer (2017-2018)
Figure Global Iguratimod Revenue Market Share by Manufacturer in 2017
Figure Global Iguratimod Revenue Market Share by Manufacturer in 2018
Figure Top 3 Iguratimod Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Iguratimod Manufacturer (Revenue) Market Share in 2018
Figure Global Iguratimod Sales and Growth Rate (2014-2019)
Figure Global Iguratimod Revenue and Growth Rate (2014-2019)
Table Global Iguratimod Sales by Regions (2014-2019)
Table Global Iguratimod Sales Market Share by Regions (2014-2019)
Table Global Iguratimod Revenue by Regions (2014-2019)
Figure Global Iguratimod Revenue Market Share by Regions (2014-2019)
Figure Global Iguratimod Revenue Market Share by Regions in 2018
Figure North America Iguratimod Sales and Growth Rate (2014-2019)
Figure Europe Iguratimod Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Iguratimod Sales and Growth Rate (2014-2019)
Figure South America Iguratimod Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Iguratimod Sales and Growth Rate (2014-2019)
Figure North America Iguratimod Revenue and Growth Rate (2014-2019)
Table North America Iguratimod Sales by Countries (2014-2019)
Table North America Iguratimod Sales Market Share by Countries (2014-2019)
Figure North America Iguratimod Sales Market Share by Countries (2014-2019)
Figure North America Iguratimod Sales Market Share by Countries in 2018
Table North America Iguratimod Revenue by Countries (2014-2019)
Table North America Iguratimod Revenue Market Share by Countries (2014-2019)
Figure North America Iguratimod Revenue Market Share by Countries (2014-2019)
Figure North America Iguratimod Revenue Market Share by Countries in 2018
Figure United States Iguratimod Sales and Growth Rate (2014-2019)
Figure Canada Iguratimod Sales and Growth Rate (2014-2019)
Figure Mexico Iguratimod Sales and Growth Rate (2014-2019)
Figure Europe Iguratimod Revenue and Growth Rate (2014-2019)
Table Europe Iguratimod Sales by Countries (2014-2019)
Table Europe Iguratimod Sales Market Share by Countries (2014-2019)
Table Europe Iguratimod Revenue by Countries (2014-2019)
Figure Europe Iguratimod Revenue Market Share by Countries (2014-2019)
Figure Europe Iguratimod Revenue Market Share by Countries in 2018
Figure Germany Iguratimod Sales and Growth Rate (2014-2019)
Figure UK Iguratimod Sales and Growth Rate (2014-2019)
Figure France Iguratimod Sales and Growth Rate (2014-2019)
Figure Russia Iguratimod Sales and Growth Rate (2014-2019)
Figure Italy Iguratimod Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Iguratimod Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Iguratimod Sales by Countries (2014-2019)
Table Asia-Pacific Iguratimod Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Iguratimod Sales Market Share by Countries 2018
Table Asia-Pacific Iguratimod Revenue by Countries (2014-2019)
Figure Asia-Pacific Iguratimod Revenue Market Share by Countries 2018
Figure China Iguratimod Sales and Growth Rate (2014-2019)
Figure Japan Iguratimod Sales and Growth Rate (2014-2019)
Figure Korea Iguratimod Sales and Growth Rate (2014-2019)
Figure India Iguratimod Sales and Growth Rate (2014-2019)
Figure Southeast Asia Iguratimod Sales and Growth Rate (2014-2019)
Figure South America Iguratimod Revenue and Growth Rate (2014-2019)
Table South America Iguratimod Sales by Countries (2014-2019)
Table South America Iguratimod Sales Market Share by Countries (2014-2019)
Figure South America Iguratimod Sales Market Share by Countries in 2018
Table South America Iguratimod Revenue by Countries (2014-2019)
Table South America Iguratimod Revenue Market Share by Countries (2014-2019)
Figure South America Iguratimod Revenue Market Share by Countries in 2018
Figure Brazil Iguratimod Sales and Growth Rate (2014-2019)
Figure Argentina Iguratimod Sales and Growth Rate (2014-2019)
Figure Colombia Iguratimod Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Iguratimod Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Iguratimod Sales by Countries (2014-2019)
Table Middle East and Africa Iguratimod Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Iguratimod Sales Market Share by Countries in 2018
Table Middle East and Africa Iguratimod Revenue by Countries (2014-2019)
Table Middle East and Africa Iguratimod Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Iguratimod Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Iguratimod Revenue Market Share by Countries in 2018
Figure Saudi Arabia Iguratimod Sales and Growth Rate (2014-2019)
Figure UAE Iguratimod Sales and Growth Rate (2014-2019)
Figure Egypt Iguratimod Sales and Growth Rate (2014-2019)
Figure Nigeria Iguratimod Sales and Growth Rate (2014-2019)
Figure South Africa Iguratimod Sales and Growth Rate (2014-2019)
Table Global Iguratimod Sales by Type (2014-2019)
Table Global Iguratimod Sales Share by Type (2014-2019)
Table Global Iguratimod Revenue by Type (2014-2019)
Table Global Iguratimod Revenue Share by Type (2014-2019)
Figure Global 14 Pcs/Box Sales Growth (2014-2019)
Figure Global 14 Pcs/Box Price (2014-2019)
Figure Global 100 Pcs/Box Sales Growth (2014-2019)
Figure Global 100 Pcs/Box Price (2014-2019)
Table Global Iguratimod Sales by Application (2014-2019)
Table Global Iguratimod Sales Share by Application (2014-2019)
Figure Global Immunoregulation Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Iguratimod Sales, Revenue and Growth Rate (2019-2024)
Table Global Iguratimod Sales Forecast by Regions (2019-2024)
Table Global Iguratimod Market Share Forecast by Regions (2019-2024)
Figure North America Sales Iguratimod Market Forecast (2019-2024)
Figure Europe Sales Iguratimod Market Forecast (2019-2024)
Figure Asia-Pacific Sales Iguratimod Market Forecast (2019-2024)
Figure South America Sales Iguratimod Market Forecast (2019-2024)
Figure Middle East and Africa Sales Iguratimod Market Forecast (2019-2024)
Table Global Iguratimod Sales Forecast by Type (2019-2024)
Table Global Iguratimod Market Share Forecast by Type (2019-2024)
Table Global Iguratimod Sales Forecast by Application (2019-2024)
Table Global Iguratimod Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List